Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG27334

ARPC5L Knockout HAP1 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone Marrow

  • Disease:

    Chronic myeloid leukemia

ARPC5L Knockout HAP1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal cell population with disrupted ARPC5L, encoding a subunit of the Arp2/3 complex. Engineered in the near-haploid HAP1 human myeloid leukemia cell line, this knockout model simplifies functional genomics studies of actin dynamics. ARPC5L, activated by N-WASP, WAVE, and Rho GTPases Rac1/Cdc42, promotes branched actin polymerization essential for cell motility, endocytosis, and adhesion. Disruption impairs these processes, making the cells valuable for cytoskeletal remodeling and cancer migration studies. Applications include Western blotting, immunofluorescence for F-actin, migration assays, and co-immunoprecipitation of the Arp2/3 complex, supporting metastasis research and drug discovery.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HAP1

    Sex of Donor

    Male

    Age

    40 years

    Derived From Site

    Bone marrow

    Gene Name

    ARPC5L

    Gene Identifier

    NCBI Gene ID 81873

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    IMDM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The ARPC5L Knockout HAP1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population designed to disrupt the human ARPC5L gene in the HAP1 cell line. This mixed-pool product provides a heterogeneous collection of loss-of-function alleles, enabling functional studies without clonal selection effects. It facilitates investigation of ARPC5L roles in actin cytoskeleton remodeling, cell motility, and endocytosis. As a polyclonal knockout, it offers population-level gene disruption suitable for assays where average gene ablation is required. Researchers can use this system to dissect the contribution of ARPC5L to Arp2/3 complex activity in a haploid genetic background.

The HAP1 host cell line is a near-haploid human myeloid leukemia cell line derived from KBM-7 cells, originally isolated from a chronic myeloid leukemia patient. The haploid karyotype simplifies CRISPR/Cas9-mediated gene disruption, as targeting a single allele yields a loss-of-function phenotype, eliminating the need for biallelic inactivation. HAP1 cells are widely used in functional genomics and high-throughput genetic screens due to this feature. They grow adherently and maintain key cancer-relevant signaling pathways, including those regulating actin dynamics, making them an appropriate model for ARPC5L knockout studies.

ARPC5L encodes a subunit of the Arp2/3 complex, the primary nucleator of branched actin networks. The complex is activated by nucleation-promoting factors such as N-WASP and the WAVE complex, themselves stimulated by Rho GTPases Rac1 and Cdc42, and by PIP2. ARPC5L interacts with all core Arp2/3 subunits (ARP2, ARP3, ARPC1-4) and associates with cortactin and WIP. This machinery drives actin polymerization, generating lamellipodia and filopodia-like protrusions, and powers endocytic vesicle trafficking and cell adhesion. Consequently, ARPC5L is critical for cell migration and intracellular transport.

In HAP1 cells, loss of ARPC5L disrupts Arp2/3 complex integrity, leading to aberrant actin organization and impaired cell motility, endocytosis, and adhesion. Given the leukemic origin of HAP1, this model is particularly relevant for examining how actin remodeling contributes to cancer cell invasion and metastasis. The adherent culture format permits high-resolution fluorescence imaging of F-actin using phalloidin, allowing direct visualization of cytoskeletal defects. The polyclonal knockout population assesses the overall functional impact without the adaptation biases of single-cell clones.

These polyclonal knockout cells are suitable for a range of assays. Western blotting and RT-qPCR can verify ARPC5L depletion, while immunofluorescence microscopy reveals altered F-actin organization. Migration and invasion can be measured via transwell or scratch assays. Co-immunoprecipitation experiments can probe Arp2/3 complex assembly. Applications span cancer metastasis research, where the cells help clarify the role of branched actin in tumor dissemination, and drug discovery, screening for modulators of actin dynamics. For additional information and ordering, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)